Ding Ye1, Danjie Jiang1, Yingjun Li2, Mingjuan Jin1, Kun Chen3. 1. Department of Epidemiology and Health Statistics, Zhejiang University School of Public Health, 866 Yuhangtang Road, Hangzhou, 310058, China. 2. Department of Public Health, Hangzhou Medical School, Hangzhou, China. 3. Department of Epidemiology and Health Statistics, Zhejiang University School of Public Health, 866 Yuhangtang Road, Hangzhou, 310058, China. ck@zju.edu.cn.
Abstract
BACKGROUND: The prognostic value of long interspersed nucleotide element-1 (LINE-1) methylation in patients with colorectal cancer (CRC) remains uncertain. We have therefore performed a meta-analysis to elucidate this issue. METHODS: The PubMed and Web of Science databases were searched for studies published up to 30 June 2016 which reported on an association between LINE-1 methylation and overall survival (OS), disease-free survival (DFS), or cancer-specific survival (CSS) among CRC patients. The reference lists of the identified studies were also analyzed to identify additional eligible studies. Hazard ratios (HRs) with 95% confidence intervals (CIs) were pooled using the fixed-effects or the random-effects model. Stratification analysis and meta-regression analysis were performed to detect the source of heterogeneity. Analyses of sensitivity and publication bias were also carried out. RESULTS: Thirteen independent studies involving 3620 CRC patients were recruited to the meta-analysis. LINE-1 hypomethylation was found to be significantly associated with shorter OS (HR 2.92, 95% CI 2.20-3.88, p < 0.001) and DFS (HR 2.18, 95% CI 1.46-3.27, p < 0.001), as well as unfavorable CSS (HR 1.96, 95% CI 1.35-2.85, p < 0.001). No heterogeneity was found among the studies evaluating the associations between LINE-1 hypomethylation and OS or DFS, with the exception being CSS. Moreover, meta-regression analysis suggested that one of the contributors to between-study heterogeneity on the association between LINE-1 methylation and CSS was statistical methodology. The subgroup analysis suggested that the association in studies using the Cox model statistical method (HR 2.76, 95% CI 1.90-4.01, p < 0.001) was stronger than that in studies using the Log-rank test (HR 1.41, 95% CI 1.07-1.87, p = 0.015). CONCLUSIONS: The results of this meta-analysis suggest that LINE-1 methylation is significantly associated with the survival of CRC patients and that it could be a predictive factor for CRC prognosis.
BACKGROUND: The prognostic value of long interspersed nucleotide element-1 (LINE-1) methylation in patients with colorectal cancer (CRC) remains uncertain. We have therefore performed a meta-analysis to elucidate this issue. METHODS: The PubMed and Web of Science databases were searched for studies published up to 30 June 2016 which reported on an association between LINE-1 methylation and overall survival (OS), disease-free survival (DFS), or cancer-specific survival (CSS) among CRC patients. The reference lists of the identified studies were also analyzed to identify additional eligible studies. Hazard ratios (HRs) with 95% confidence intervals (CIs) were pooled using the fixed-effects or the random-effects model. Stratification analysis and meta-regression analysis were performed to detect the source of heterogeneity. Analyses of sensitivity and publication bias were also carried out. RESULTS: Thirteen independent studies involving 3620 CRC patients were recruited to the meta-analysis. LINE-1 hypomethylation was found to be significantly associated with shorter OS (HR 2.92, 95% CI 2.20-3.88, p < 0.001) and DFS (HR 2.18, 95% CI 1.46-3.27, p < 0.001), as well as unfavorable CSS (HR 1.96, 95% CI 1.35-2.85, p < 0.001). No heterogeneity was found among the studies evaluating the associations between LINE-1 hypomethylation and OS or DFS, with the exception being CSS. Moreover, meta-regression analysis suggested that one of the contributors to between-study heterogeneity on the association between LINE-1 methylation and CSS was statistical methodology. The subgroup analysis suggested that the association in studies using the Cox model statistical method (HR 2.76, 95% CI 1.90-4.01, p < 0.001) was stronger than that in studies using the Log-rank test (HR 1.41, 95% CI 1.07-1.87, p = 0.015). CONCLUSIONS: The results of this meta-analysis suggest that LINE-1 methylation is significantly associated with the survival of CRC patients and that it could be a predictive factor for CRC prognosis.
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: Naohiko Akimoto; Melissa Zhao; Tomotaka Ugai; Rong Zhong; Mai Chan Lau; Kenji Fujiyoshi; Junko Kishikawa; Koichiro Haruki; Kota Arima; Tyler S Twombly; Xuehong Zhang; Edward L Giovannucci; Kana Wu; Mingyang Song; Andrew T Chan; Yin Cao; Jeffrey A Meyerhardt; Kimmie Ng; Marios Giannakis; Juha P Väyrynen; Jonathan A Nowak; Shuji Ogino Journal: Cancers (Basel) Date: 2021-04-22 Impact factor: 6.639
Authors: Pooja R Mandaviya; Roby Joehanes; Jennifer Brody; Juan E Castillo-Fernandez; Koen F Dekkers; Anh N Do; Mariaelisa Graff; Ismo K Hänninen; Toshiko Tanaka; Ester A L de Jonge; Jessica C Kiefte-de Jong; Devin M Absher; Stella Aslibekyan; Yolanda B de Rijke; Myriam Fornage; Dena G Hernandez; Mikko A Hurme; M Arfan Ikram; Paul F Jacques; Anne E Justice; Douglas P Kiel; Rozenn N Lemaitre; Michael M Mendelson; Vera Mikkilä; Ann Z Moore; Tess Pallister; Olli T Raitakari; Casper G Schalkwijk; Jin Sha; Eline P E Slagboom; Caren E Smith; Coen D A Stehouwer; Pei-Chien Tsai; André G Uitterlinden; Carla J H van der Kallen; Diana van Heemst; Donna K Arnett; Stefania Bandinelli; Jordana T Bell; Bastiaan T Heijmans; Terho Lehtimäki; Daniel Levy; Kari E North; Nona Sotoodehnia; Marleen M J van Greevenbroek; Joyce B J van Meurs; Sandra G Heil Journal: Am J Clin Nutr Date: 2019-08-01 Impact factor: 8.472
Authors: Hatim Boughanem; Gracia María Martin-Nuñez; Esperanza Torres; Isabel Arranz-Salas; Julia Alcaide; Sonsoles Morcillo; Francisco J Tinahones; Ana B Crujeiras; Manuel Macias-Gonzalez Journal: J Pers Med Date: 2020-11-11
Authors: Krisztina A Szigeti; Barbara K Barták; Zsófia B Nagy; Sára Zsigrai; Márton Papp; Eszter Márkus; Peter Igaz; István Takács; Béla Molnár; Alexandra Kalmár Journal: Int J Mol Sci Date: 2022-10-01 Impact factor: 6.208